Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.

Abstract:

:A monoclonal immunoglobulin M (IgM) antibody (38-13) which recognizes Burkitt's lymphoma (BL) cells, by reacting with the neutral glycolipid Gal alpha 1 leads to 4-Gal beta 1 leads to 4-Glc beta 1 leads to 1-ceramide, was recently characterized. This monoclonal IgM was coupled to either ricin A chain or gelonin. The two different immunotoxins obtained retained the apparent immunological specificity of 38-13 IgM, as shown by flow cytofluorometry analysis and complement-dependent cytotoxicity test. The BL Ramos cells and the apparently irrelevant Epstein-Barr virus-containing lymphoblastoid Priess cells were used as targets in in vitro assays of the cytotoxic properties of the two immunotoxins by measuring the inhibition of protein synthesis. Isolated ricin A chain, gelonin, and 38-13 IgM exhibited very low intrinsic cytotoxicity on both target cells. 38-13 ricin A chain and 38-13 gelonin conjugates exerted toxic effects on both target cells which were about 6000-fold and 3000-fold higher than uncoupled ricin A chain and gelonin, respectively. The toxicity of these conjugates almost reached that of intact ricin. On Ramos BL cells, the kinetics of action of the 38-13 ricin A chain conjugate was almost as fast as that of intact ricin, because 50% protein synthesis inhibition was reached after 3 hr. In contrast, the kinetics of action in the non-BL Priess was much slower (50% protein synthesis inhibition after 10 hr). An obviously irrelevant immunotoxin (anti-trinitrophenol IgM-ricin A chain) had no significant cytotoxic effect on BL Ramos and non-BL Priess cells. An excess of D-galactose was shown previously to inhibit the 38-13 IgM from binding to the reactive glycolipid antigen bearing a terminal galactose. An excess of D-galactose (0.1 M) inhibited the cytotoxic effect of the two 38-13 immunotoxins, whereas it did not prevent the cytotoxic effect of the anti-trinitrophenol immunotoxin on the same trinitrophenol labeled target cells. These data suggest that the cytotoxic effect observed with 38-13 immunotoxins on non-BL Priess cells was mediated through their binding to a very low number of antigenic sites undetectable by conventional immunological methods. The main characteristics of 38-13 immunotoxins appear to be their fast kinetics of action and the very low number of antigenic sites required for the expression of their toxic effects. These properties could be related to the glycolipid nature of the reacting antigen. Such glycolipid antigens would represent valuable targets for therapeutic use of immunotoxins.

journal_name

Cancer Res

journal_title

Cancer research

authors

Wiels J,Junqua S,Dujardin P,Le Pecq JB,Tursz T

subject

Has Abstract

pub_date

1984-01-01 00:00:00

pages

129-33

issue

1

eissn

0008-5472

issn

1538-7445

journal_volume

44

pub_type

杂志文章
  • Osteoclasts direct bystander killing of bone cancer.

    abstract::Primary and metastatic bone cancers are difficult to eradicate and novel approaches are needed to improve treatment and extend life. As bone cancer grows, osteoclasts, the principal bone-resorbing cells of the body, are recruited to and activated at sites of cancer. In this investigation, we determined if osteoclast l...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1295

    authors: Ramnaraine ML,Mathews WE,Donohue JM,Lynch CM,Goblirsch MJ,Clohisy DR

    更新日期:2006-11-15 00:00:00

  • NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells.

    abstract::The NY-ESO-1 gene product is expressed by a range of human tumors and is recognized by antibodies from sera of cancer patients with NY-ESO-1-expressing tumors. The NY-ESO-1 gene also encodes several MHC class I- and MHC class II-restricted tumor epitopes recognized by T lymphocytes. In particular, we previously report...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zarour HM,Maillere B,Brusic V,Coval K,Williams E,Pouvelle-Moratille S,Castelli F,Land S,Bennouna J,Logan T,Kirkwood JM

    更新日期:2002-01-01 00:00:00

  • Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.

    abstract::Highly glycolytic cervical cancers largely resist treatment by cisplatin and coadministered pelvic irradiation as the present standard of care. In this study, we investigated the effects of inhibiting glycolysis and thiol redox metabolism to evaluate them as alternate treatment strategies in these cancers. In a panel ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-2367

    authors: Rashmi R,Huang X,Floberg JM,Elhammali AE,McCormick ML,Patti GJ,Spitz DR,Schwarz JK

    更新日期:2018-03-15 00:00:00

  • A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells.

    abstract::A major obstacle to successful treatment of colorectal cancer is chemotherapy resistance. Enhanced expression of variant CD44 isoforms has been associated with aggressive tumor behavior, prompting the question of whether signaling from this receptor might modulate drug sensitivity. Activation of variant CD44 in colon ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bates RC,Edwards NS,Burns GF,Fisher DE

    更新日期:2001-07-01 00:00:00

  • Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.

    abstract::Ovarian cancer is resistant to the antiproliferative effects of transforming growth factor-beta (TGF-beta); however, the mechanism of this resistance remains unclear. We used oligonucleotide arrays to profile 37 undissected, 68 microdissected advanced-stage, and 14 microdissected early-stage papillary serous cancers t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-0683

    authors: Sunde JS,Donninger H,Wu K,Johnson ME,Pestell RG,Rose GS,Mok SC,Brady J,Bonome T,Birrer MJ

    更新日期:2006-09-01 00:00:00

  • Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

    abstract::The antitumor activity of IFN-alpha is well established. However, the role of the plasmacytoid dendritic cell (PDC), the major producer of IFN-alpha upon viral infection, in tumor biology is unknown. We sought to study the presence and function of PDC in a human solid tumor. Here, we demonstrate that PDCs infiltrate t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hartmann E,Wollenberg B,Rothenfusser S,Wagner M,Wellisch D,Mack B,Giese T,Gires O,Endres S,Hartmann G

    更新日期:2003-10-01 00:00:00

  • Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.

    abstract::Cancer vaccines may have applications in the therapy and prevention of mammary carcinoma. To investigate such applications, we constructed a recombinant adenoviral vaccine expressing a kinase-inactive mutant form of human HER2 and introduced this into BALB/c wild-type (WT) or HER2 transgenic mice. Here, we report cont...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0493

    authors: Triulzi C,Vertuani S,Curcio C,Antognoli A,Seibt J,Akusjärvi G,Wei WZ,Cavallo F,Kiessling R

    更新日期:2010-10-01 00:00:00

  • The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomas.

    abstract::Glioblastoma multiforme is a fatal malignancy of the central nervous system, demanding new methods of treatment. The combination of a calmodulin antagonist with bleomycin has shown synergistic activity in several preclinical models and has been evaluated in a Phase I clinical trial. Since phenothiazines reach high con...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Hait WN,Byrne TN,Piepmeier J,Durivage HJ,Choudhury S,Davis CA,Gates JA

    更新日期:1990-10-15 00:00:00

  • Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal.

    abstract::This paper describes the reactions of purine nucleosides and nucleic acids with 2,3-epoxy-4-hydroxynonanal. 2,3-Epoxy-4-hydroxynonanal was produced with tert-butyl hydroperoxide by epoxidation of trans-4-hydroxy-2-nonenal, a lipid peroxidation product. The epoxy aldehyde exists as a pair of diastereomers, I and II. Be...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sodum RS,Chung FL

    更新日期:1991-01-01 00:00:00

  • p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.

    abstract::Fifty-eight skin biopsies and three primary internal tumors from patients affected by the rare hereditary disease xeroderma pigmentosum (XP) were studied by an improved PCR-single strand conformation polymorphism analysis to detect the mutations of the tumor suppressor gene p53. The results from cutaneous XP tumors, i...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Giglia G,Dumaz N,Drougard C,Avril MF,Daya-Grosjean L,Sarasin A

    更新日期:1998-10-01 00:00:00

  • Akt SUMOylation regulates cell proliferation and tumorigenesis.

    abstract::Proto-oncogene Akt plays essential roles in cell proliferation and tumorigenesis. Full activation of Akt is regulated by phosphorylation, ubiquitination, and acetylation. Here we report that SUMOylation of Akt is a novel mechanism for its activation. Systematically analyzing the role of lysine residues in Akt activati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0538

    authors: Li R,Wei J,Jiang C,Liu D,Deng L,Zhang K,Wang P

    更新日期:2013-09-15 00:00:00

  • Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance.

    abstract::Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer deaths in the United States. The deoxynucleoside analogue gemcitabine is among the most effective therapies to treat PDAC, however, nearly all patients treated with gemcitabine either fail to respond or rapidly develop resistance. One hallmark of PDA...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-0960

    authors: Dalin S,Sullivan MR,Lau AN,Grauman-Boss B,Mueller HS,Kreidl E,Fenoglio S,Luengo A,Lees JA,Vander Heiden MG,Lauffenburger DA,Hemann MT

    更新日期:2019-11-15 00:00:00

  • Reduced toxicity and enhanced antitumor effects in mice of the ionophoric drug valinomycin when incorporated in liposomes.

    abstract::Valinomycin (NSC 122023) is a cyclic depsipeptide antibiotic with potassium selective ionophoric activity. This drug has been reported to display antitumor effects but its utilization has been limited by its extreme toxicity. Here we report that the incorporation of valinomycin into multilamellar liposomes composed of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Daoud SS,Juliano RL

    更新日期:1986-11-01 00:00:00

  • Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.

    abstract::Ubiquitination and ubiquitin-like posttranslational modifications (PTM) regulate activity and stability of oncoproteins and tumor suppressors. This implicates PTMs as antineoplastic targets. One way to alter PTMs is to inhibit activity of deubiquitinases (DUB) that remove ubiquitin or ubiquitin-like proteins from subs...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-17-1752

    authors: Mustachio LM,Lu Y,Kawakami M,Roszik J,Freemantle SJ,Liu X,Dmitrovsky E

    更新日期:2018-02-01 00:00:00

  • Targeting ERBB receptors shifts their partners and triggers persistent ERK signaling through a novel ERBB/EFNB1 complex.

    abstract::Most squamous cell carcinomas of the head and neck (HNSCC) overexpress ERBB1/EGFR, but EGF receptor (EGFR)-targeted therapies have yielded disappointing clinical results in treatment of this cancer. Here, we describe a novel interaction between EGFR and the ligand EphrinB1 (EFNB1), and we show that EFNB1 phosphorylati...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0760

    authors: Vermeer PD,Colbert PL,Wieking BG,Vermeer DW,Lee JH

    更新日期:2013-09-15 00:00:00

  • Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis.

    abstract::It is currently widely accepted that genetic instability is key to cancer development. Many types of cancers arise as a consequence of a gradual accumulation of nucleotide aberrations, each mutation conferring growth and/or survival advantage. Genetic instability could also proceed in sudden bursts leading to a more d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bavoux C,Leopoldino AM,Bergoglio V,O-Wang J,Ogi T,Bieth A,Judde JG,Pena SD,Poupon MF,Helleday T,Tagawa M,Machado C,Hoffmann JS,Cazaux C

    更新日期:2005-01-01 00:00:00

  • Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry.

    abstract::Merkel cell carcinoma (MCC) is a highly malignant neuroendocrine nonmelanoma skin cancer, which is associated with the Merkel cell polyoma virus (MCPyV). Recently, expression of the terminal deoxynucleotidyl transferase (TdT) and the paired box gene 5 (PAX 5) has been consistently reported in the majority of MCCs. We ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0616

    authors: Zur Hausen A,Rennspiess D,Winnepenninckx V,Speel EJ,Kurz AK

    更新日期:2013-08-15 00:00:00

  • Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.

    abstract::LMO2 is a transcription regulator involved in human T-cell leukemia, including some occurring in X-SCID gene therapy trials, and in B-cell lymphomas and prostate cancer. LMO2 functions in transcription complexes via protein-protein interactions involving two LIM domains and causes a preleukemic T-cell development bloc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4774

    authors: Appert A,Nam CH,Lobato N,Priego E,Miguel RN,Blundell T,Drynan L,Sewell H,Tanaka T,Rabbitts T

    更新日期:2009-06-01 00:00:00

  • Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.

    abstract::MicroRNAs (miRNAs) are a new class of short noncoding regulatory RNAs (18-25 nucleotides) that are involved in diverse developmental and pathologic processes. Altered miRNA expression has been associated with several types of human cancer. However, most studies did not establish whether miRNA expression changes occurr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5019

    authors: Sempere LF,Christensen M,Silahtaroglu A,Bak M,Heath CV,Schwartz G,Wells W,Kauppinen S,Cole CN

    更新日期:2007-12-15 00:00:00

  • Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456).

    abstract::Pyrazine diazohydroxide (PZDH) is a novel antineoplastic agent that appears to form DNA adducts via the reactive pyrazine diazonium ion and produces substantial antitumor activity in preclinical models. We conducted a phase I trial to determine the maximally tolerated dose of PZDH that could be administered as a 5-min...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Vogelzang NJ,Mick R,Janisch L,Berezin F,Schilsky RL,Ratain MJ

    更新日期:1994-01-01 00:00:00

  • Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.

    abstract::Antivascular therapy directed against VEGF or its receptors (VEGFR) has been successful when administered at early stages of tumor vessel growth but is less effective when administered later. Tumor blood vessels are heterogeneous, so vessel subpopulations may differ in their requirements for tumor cell-secreted VEGF a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-1693

    authors: Sitohy B,Nagy JA,Jaminet SC,Dvorak HF

    更新日期:2011-11-15 00:00:00

  • Immune-mediated arrest and reversal of established visceral metastases in athymic mice.

    abstract::The metastasizing MDAY-D2 tumor of DBA/2 mice disseminates in BALB/c allogeneic athymic nude (nu/nu) mice in a manner identical to that observed in the syngeneic host. Both the kinetics and organ distribution pattern of metastases from s.c. implants of MDAY-D2 are routinely predictable at any given tumor dose. BALB/c ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wiltrout RH,Frost P,Morrison MK,Kerbel RS

    更新日期:1979-10-01 00:00:00

  • SRC-3 is required for prostate cancer cell proliferation and survival.

    abstract::Prostate cancer is the most common cancer in men in America. Currently, steroid receptor coactivators have been proposed to mediate the development and progression of prostate cancer, at times in a steroid-independent manner. Steroid receptor coactivator-3 (SRC-3, p/CIP, AIB1, ACTR, RAC3, and TRAM-1) is a member of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-4076

    authors: Zhou HJ,Yan J,Luo W,Ayala G,Lin SH,Erdem H,Ittmann M,Tsai SY,Tsai MJ

    更新日期:2005-09-01 00:00:00

  • Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.

    abstract::Human prostate cancer is associated with a reactive stroma typified by an increase in the proportion of myofibroblast type cells and elevated synthesis of extracellular matrix proteins. Increased vascular density has been identified in the reactive stroma compartment adjacent to both precancerous and cancerous prostat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McAlhany SJ,Ressler SJ,Larsen M,Tuxhorn JA,Yang F,Dang TD,Rowley DR

    更新日期:2003-09-15 00:00:00

  • Effects of nine N-nitroso compounds on the specific radioactivity of liver proteins after injection of [14C]leucine into rats.

    abstract::We compared the effect of nine N-nitroso compounds, given by gavage to adult rats, on specific radioactivity of the trichloroacetic acid-precipitable liver proteins, 1 hr after the injection of [14C]leucine. The specific radioactivity was decreased by dimethylnitrosamine, diethylnitrosamine, methyl-n-butylnitrosamine,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chu C,Mirvish SS

    更新日期:1977-05-01 00:00:00

  • Cyclic adenosine 3':5'-monophosphate and methotrexate transport in L1210 cells.

    abstract::Treatment of L1210 cells with glucose, 1-methyl-3-isobutylxanthine, theophylline, and prostaglandins E1 and E2 was used to increase to varying degrees the endogenous level of cyclic adenosine 3':5'-monophosphate (cAMP). In an inverse manner these agents decreased the rate of methotrexate (MTX) transport into the cells...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Henderson GB,Zevely EM,Huennekens FM

    更新日期:1978-03-01 00:00:00

  • Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.

    abstract::3-phosphoinositide-dependent protein kinase-1 (PDK1) plays a pivotal role in coupling growth factor receptor signaling to tumor cell proliferation, survival, and invasion. Protein kinase C (PKC) alpha, but not Akt1, was found previously to be downstream of PDK1-mediated transformation of mammary epithelial cells. To d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Xie Z,Zeng X,Waldman T,Glazer RI

    更新日期:2003-09-01 00:00:00

  • Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.

    abstract::In vitro experiments selected optimal conditions to radiolabel with 131I the whole immunoglobulin and F(ab')2 fragments of the monoclonal antibody (MoAb) 225.28S to a high-molecular-weight melanoma-associated antigen (HMW-MAA). Injection of the radiolabeled whole immunoglobulin and F(ab')2 fragments of the MoAb 225.28...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Buraggi GL,Callegaro L,Mariani G,Turrin A,Cascinelli N,Attili A,Bombardieri E,Terno G,Plassio G,Dovis M

    更新日期:1985-07-01 00:00:00

  • An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer.

    abstract::Kinase inhibitors are used widely to treat various cancers, but adaptive reprogramming of kinase cascades and activation of feedback loop mechanisms often contribute to therapeutic resistance. Determining comprehensive, accurate maps of kinase circuits may therefore help elucidate mechanisms of response and resistance...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-15-2325-T

    authors: Olow A,Chen Z,Niedner RH,Wolf DM,Yau C,Pankov A,Lee EP,Brown-Swigart L,van 't Veer LJ,Coppé JP

    更新日期:2016-04-01 00:00:00

  • Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells.

    abstract::The influence of gangliosides on tumor growth and frequency of metastasis in vivo as well as on growth and motility of neoplastic cells in vitro was tested utilizing human and rodent cell populations. In mice receiving injections of a ganglioside mixture twice daily the tumor volume, the number of spontaneous metastas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alessandri G,Filippeschi S,Sinibaldi P,Mornet F,Passera P,Spreafico F,Cappa PM,Gullino PM

    更新日期:1987-08-15 00:00:00